Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant
Alexandra Higgins(Mayo Clinic), Mrinal M. Patnaik(Mayo Clinic), Charles C. Coddington(Mayo Clinic in Arizona), Shahrukh K. Hashmi(Mayo Clinic), Zaraq Khan(The University of Texas at San Antonio Health Science Center), Hassan B. Alkhateeb(Mayo Clinic), Mehrdad Hefazi(Mayo Clinic), William J. Hogan(Mayo Clinic), Carrie A. Thompson(Mayo Clinic), Mark R. Litzow(Dana-Farber Cancer Institute), Elizabeth Cathcart-Rake(Mayo Clinic)
Cited by 13
Related Papers
Inherited antithrombin deficiency: a review
|Haemophilia|2008|396
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
|Blood|2017|296
Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment
|BMJ|2017|253
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
|Haematologica|2021|236
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease
|Haematologica|2019|215